# Margus Viigimaa

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/margus-viigimaa/

## Facts

| Field | Value |
| --- | --- |
| Citations | 75,645 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 54 |
| i10-index | 110 |
| Last Known Institution | Tallinn University of Technology |
| OpenAlex ID | https://openalex.org/A5013595648 |
| ORCID iD | https://orcid.org/0000-0001-5575-5978 |
| Works | 234 |

## Researcher papers

- [European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)](https://scholariq.org/papers/european-guidelines-on-cardiovascular-disease-prevention-in-clinical-practice-5/)
- [2013 ESH/ESC Guidelines for the management of arterial hypertension](https://scholariq.org/papers/2013-esh-esc-guidelines-for-the-management-of-arterial-hypertension-2/)
- [2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk](https://scholariq.org/papers/2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias-lipid-modification/)
- [ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)](https://scholariq.org/papers/esc-eas-guidelines-for-the-management-of-dyslipidaemias-the-task-force-for-the/)
- [2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)](https://scholariq.org/papers/2007-guidelines-for-the-management-of-arterial-hypertension-the-task-force-for/)
- [2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease](https://scholariq.org/papers/2020-esc-guidelines-on-sports-cardiology-and-exercise-in-patients-with/)
- [Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document](https://scholariq.org/papers/reappraisal-of-european-guidelines-on-hypertension-management-a-european-society-2/)
- [2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes](https://scholariq.org/papers/2023-esc-guidelines-for-the-management-of-cardiovascular-disease-in-patients/)
- [European Society of Cardiology: Cardiovascular Disease Statistics 2019](https://scholariq.org/papers/european-society-of-cardiology-cardiovascular-disease-statistics-2019/)
- [Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document](https://scholariq.org/papers/reappraisal-of-european-guidelines-on-hypertension-management-a-european-society/)
- [Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial](https://scholariq.org/papers/effects-of-alirocumab-on-cardiovascular-and-metabolic-outcomes-after-acute/)
- [Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)](https://scholariq.org/papers/global-perspective-of-familial-hypercholesterolaemia-a-cross-sectional-study/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cardiovascular Health and Disease Prevention](https://scholariq.org/topics/cardiovascular-health-and-disease-prevention/)
- [Non-Invasive Vital Sign Monitoring](https://scholariq.org/topics/non-invasive-vital-sign-monitoring/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

## Researcher university

- [Tallinn University of Technology](https://scholariq.org/institutions/tallinn-university-of-technology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.